Nav: Home

Fewer than half of US adults exposed to court-ordered anti-smoking advertisements

July 12, 2019

The tobacco industry's court-ordered anti-smoking advertisements reached just 40.6% of U.S. adults and 50.5% of current smokers in 2018, according to new research from The University of Texas MD Anderson Cancer Center. Exposure to the advertisements was even lower among certain ethnic and socioeconomic subgroups historically targeted by tobacco industry marketing.

The findings, published today in JAMA Network Open, should be considered when planning future anti-smoking ads to reach youth and at-risk populations, explained senior author Sanjay Shete, Ph.D., professor of Biostatistics and Epidemiology and deputy division head of Cancer Prevention & Population Sciences.

"When compared to other nationally funded anti-smoking campaigns, the reach and penetration of these industry-sponsored ads were suboptimal," said Shete. "Our hope, as cancer prevention researchers, is for more people to see these ads and to avoid tobacco or consider quitting. Based on our findings, future efforts in this space need to be more targeted to reach key populations."

According to the Centers for Disease Control and Prevention (CDC), tobacco use remains the leading preventable cause of death in the U.S., claiming an estimated 480,000 lives each year. Tobacco use also is the leading preventable cause of cancer, responsible for roughly 30% of all cancers and 90% of all lung cancers.

The 'corrective statements' were mandated in a 2006 judgment by U.S. District Judge Gladys Kessler, and began to run on prime-time television and in 50 key U.S. newspapers in November 2017. MD Anderson applauded these advertisements as an important step to inform Americans about the harms of tobacco use.

The current study assessed data from 2018 Health Information National Trends Survey, a nationally representative, population-based cross-section survey of U.S. adults sponsored by the National Cancer Institute. The study analyzed responses from 3,484 adults, including 450 current smokers, collected between January and May 2018 on self-reported exposure to the anti-smoking advertisements.

Exposure was lowest among adults 18-34 (37.4%), those with a high-school or lower education (34.5%) and those with a household income less than $35,000 (37.5%). Among current smokers, exposure was lowest in the Hispanic population, at just 42.2%.

"Historically, certain ethnic groups and those of lower socioeconomic status have been targets of tobacco industry marketing, which has led to high rates of tobacco use and tobacco-related diseases in these populations," said first author Onyema Greg Chido-Amajuoyi, M.B.B.S., a postdoctoral fellow in Epidemiology. "These at-risk groups should, ideally, have had the most exposure to these advertisements, but on the contrary, they have had the least."

The researchers did find that exposure rates increased as the campaign's duration increased, with 41.3% exposure reported in February 2018 and 46.8% exposure reported in May 2018. This underscores the need for sustained advertising to see long-term public-health impact, explained Shete.

The authors recognize certain limitations in the study inherent to using a survey of this type. Responses were self-reported and therefore prone to recall and certain biases. Also, the survey is cross-sectional, so a causal link between exposure and cessation attempts cannot be made. Finally, there was no distinction between exposure to television or to print advertisements, which may have enabled further insight.
-end-
Co-authors with Shete and Chido-Amajuoyi are Robert K. Yu, of Biostatistics; and Israel Agaku, D.M.D., Ph.D., of the Harvard School of Dental Medicine, Boston, MA. The authors report no conflicts of interest.

The study was funded by the National Cancer Institute (P30CA016672), the Barnhart Family Distinguished Professorship in Targeted Therapy, the Cancer Prevention and Researcher Institute of Texas (RP170259), the Mrs. Harry C. Wiess Cancer Research Fund, and the Laura and John Arnold Foundation.

University of Texas M. D. Anderson Cancer Center

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...